Net Cash Provided by (Used in) Financing Activities of LifeMD, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
LifeMD, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • LifeMD, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $812,563, a 22% increase year-over-year.
  • LifeMD, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $13,407,012, a 226% decline from 2024.
  • LifeMD, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,118,673, a 114% decline from 2023.
  • LifeMD, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $29,100,820.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

LifeMD, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $13,407,012 -$9,288,339 -226% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $4,118,673 -$33,219,493 -114% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $29,100,820 +$29,629,020 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $528,200 -$69,164,942 -101% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 $68,636,742 +$47,634,541 +227% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $21,002,201 +$20,227,078 +2610% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
2019 $775,123 -$27,664 -3.4% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $802,787 +$26,753 +3.4% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $776,034 +$418,543 +117% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $357,491 +$32,139 +9.9% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $325,352 +$438,352 01 Jan 2015 31 Dec 2015 10-K 24 May 2017 2016 FY
2014 $113,000 -$428,200 -136% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $315,200 +$20,046 +6.8% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
2012 $295,154 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY

LifeMD, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $812,563 +$235,127 +22% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $1,047,690 -$13,039,156 -109% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $11,991,466 +$12,765,529 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $774,063 -$14,157,333 -106% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $13,383,270 +$14,324,972 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $941,702 -$957,404 -6097% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $15,702 +$183,181 01 Jan 2019 31 Mar 2019 10-Q 19 May 2020 2020 Q1
Q1 2018 $167,479 -$839,230 -125% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $671,751 +$578,958 +624% 01 Jan 2017 31 Mar 2017 10-Q 27 Jun 2018 2018 Q1
Q1 2016 $92,793 +$28,050 +43% 01 Jan 2016 31 Mar 2016 10-Q 07 Jul 2017 2017 Q1
Q1 2015 $64,743 +$76,743 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $12,000 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.